Clinical trial
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
NCT04466098
Study timeline
Study start (actual)2020-07-30Date precision: day
Registry last updated2025-01-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Acute Respiratory Distress Syndromeunresolved
ARDS (Moderate or Severe)unresolved
COVID-19 Pneumoniaunresolved
Interventions
Mesenchymal stromal cellsBIOLOGICAL
PlaceboOTHER
Sponsors & collaborators
Masonic Cancer Center, University of Minnesotalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04466098 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.